Vector-capacity of the invasive Anopheles stephensi mosquito in Ethiopia
Official title: Vectorial Capacity of Invasive Anopheles stephensi in Ethiopia
Funded at University of California-Irvine · NIH-11455143 · Data updated 2026-11-12
This grant studies how the invasive Anopheles stephensi mosquito spreads malaria in urban Ethiopia and how it might affect transmission to people.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project start | August 13, 2026 |
| Project end | July 1, 2028 |
| Funding year | 2026 |
| Award (this year) | $196,250 |
| NIH project number | 1R21AI190786-01A1 |
| Project ID | NIH-11455143 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are communities in urban Ethiopian areas where An. stephensi is present and malaria transmission is a concern, plus researchers studying vector biology.
✕Less likely to help
Communities without An. stephensi or malaria risk from this vector may see limited direct benefit.
What this research studies
Researchers at UC Irvine will look at how An. stephensi survives, bites people, and passes malaria parasites under real-world field conditions in Ethiopia. They will test vector competence for local strains of Plasmodium falciparum and P. vivax and estimate overall malaria transmission risk in urban settings. Findings could refine malaria risk maps and help guide targeted control strategies in African cities where this mosquito is spreading.
Why it matters
Potential benefit: If successful, results could improve malaria risk predictions and inform more effective vector control in urban areas affected by An. stephensi.
How similar studies have gone: Previous work has shown that An. stephensi can transmit malaria parasites in various settings, but field-based vectorial capacity assessments in Africa are still developing.
Where this research is happening
-
University of California-Irvine
Irvine, United States Active
Researchers
- Principal investigator: Yan, Guiyun — University of California-Irvine
- Study coordinator: Yan, Guiyun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.